IMNP

Immune Pharmaceuticals Inc.
IMNP

Delisted

IMNP was delisted on the 25th of July, 2018.

12 hedge funds and large institutions have $444K invested in Immune Pharmaceuticals Inc. in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$22.9K
2 +$6.04K
3 +$5.63K

Top Sellers

1 -$215K
2 -$188K
3 -$110K
4
Goldman Sachs
Goldman Sachs
New York
-$33K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$5.03K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$342K
2
$41K
3
$33K
4
$10.6K
5
$10K
6
$6K
7
$1K
8
9
10
11
12
13